# Temozolomide in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to Cisplatin

> **NCT00006043** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center**

## Conditions studied

- Ovarian Cancer
- Testicular Germ Cell Tumor

## Interventions

- **DRUG:** temozolomide

## Key facts

- **NCT ID:** NCT00006043
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-02
- **Primary completion:** 2001-11
- **Final completion:** 2001-11
- **Target enrollment:** — (—)
- **Last updated:** 2013-06-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006043, "Temozolomide in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to Cisplatin". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00006043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*